We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for formulation.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

formulation Product List and Ranking from 40 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

formulation Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

  1. シーシーアイ 住設・建材事業部　営業部 Gifu//Chemical
  2. 太陽化学 Aichi//Chemical
  3. 小松マテーレ Ishikawa//fiber
  4. 4 高保製薬工業 Fukushima//others
  5. 5 日成共益 Tokyo//Chemical
Go to Company Ranking

formulation Product ranking

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

  1. High-concentration ethanol preparation "Sunny No. 70" 太陽化学
  2. 【Technical Data】Grease-decomposing Microbial Agent 'Oil Varnish' シーシーアイ 住設・建材事業部　営業部
  3. Sludge volume reduction bio-agent "Veriformer" 小松マテーレ
  4. 4 Pickling Shelf-Life Extender Formulation "T-Fresh YZ" 高保製薬工業
  5. 5 Peracetic acid preparation "TPL Clarity" [Excellent bactericidal power against pathogens!] 日成共益

formulation Product List

241～255 item / All 260 items

Displayed results
Sodium Hypochlorite Preparation

Sodium Hypochlorite Preparation

The cut vegetables do not retain a chlorine smell and are suitable for cleaning and sterilization in the final stage.

The "sodium hypochlorite formulation" is a product for disinfecting cut vegetables, which combines sodium hypochlorite with plant-derived surfactants. Since it does not produce organic chlorine compounds, it leaves no chlorine odor on cut vegetables and is suitable for final-stage cleaning and disinfection. 【Features】 ■ Contains plant-derived surfactants with sodium hypochlorite ■ For disinfecting cut vegetables ■ Leaves no chlorine odor on cut vegetables as it does not produce organic chlorine compounds ■ Suitable for final-stage cleaning and disinfection *For more details, please refer to the external link page or feel free to contact us.

  • Sterilizing water production equipment
  • Food Cleaning Equipment

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
How to distinguish truly safe and secure disinfectants and deodorants.

How to distinguish truly safe and secure disinfectants and deodorants.

Introducing how to identify safe and secure disinfectants and deodorants, such as food additives that have received formal approval.

Products labeled as "safe and secure made from food additives" are not food additives. To produce products that are food additives, a "food additive manufacturing business" license is required. A dedicated plant that meets the cleanliness standards set by the Food Sanitation Act and passes various hygiene management checks is also necessary, and products and manufacturing methods must be inspected and approved by the health departments of each prefecture, making it a very high hurdle. From a safety perspective, we recommend products such as food additive formulations that are manufactured in facilities that have received official approval from the Ministry of Health, Labour and Welfare, the health and sanitation departments of each prefecture, and local health centers. *For more details, please refer to the PDF materials or feel free to contact us.

  • Other consumables

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【BV4 Features】Safety and Security <Disinfectant OEM>

【BV4 Features】Safety and Security <Disinfectant OEM>

Safe to use even in food handling environments! It can be stored for a long time as it is less likely to deteriorate.

We would like to introduce the features of the antiviral and antibacterial agent "BV4," focusing on its "safety and security." This product is composed entirely of "food and food additives," making it safe to use in environments that handle food. Additionally, it has low irritability and does not harm the skin. It is less likely to damage fabrics such as clothing and is resistant to discoloration. It also has a low risk of causing metal corrosion, making it suitable for hygiene management of cooking utensils and machinery. Due to its resistance to degradation from volatilization, it can be stored for long periods. 【Features (Details)】 ■ Harmless to humans ■ Considerate of the skin ■ Harmless to clothing, metals, plastics, and rubber products ■ Easy to manage *For more details, please refer to the related links or feel free to contact us.

  • Fungicides

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【BV4 Features】Effect against Coronavirus <Disinfectant OEM>

【BV4 Features】Effect against Coronavirus <Disinfectant OEM>

The effectiveness against the SARS coronavirus (official name SARS-CoV) has been confirmed!

The antiviral and antibacterial agent "BV4" has features such as "effectiveness against coronaviruses." Its effectiveness against the SARS coronavirus (officially known as SARS-CoV) has been confirmed. Additionally, it boasts 100% antiviral and antibacterial power, as well as high mold prevention capabilities. Please feel free to contact us if you have any inquiries. 【Other Features】 ■ Safe and secure ■ 100% antiviral and antibacterial power ■ High mold prevention capability (effectiveness against mold) ■ Effectiveness against avian influenza virus ■ Low odor effect *For more details, please refer to the related links or feel free to contact us.

  • Fungicides

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Biologics Market Report: 2025-2035

Biologics Market Report: 2025-2035

The increasing demand for biopharmaceuticals accelerates market growth.

The growing demand for biopharmaceuticals continues to be a major driving force behind the growth of the pharmaceutical market as of 2025. Biologics, which are derived from living organisms, are known for their high precision in targeting specific molecules or cells, leading to effective treatments with reduced side effects. This high level of precision is particularly useful in addressing complex conditions such as cancer, autoimmune diseases, and rare genetic disorders. Recent advancements are expanding the therapeutic applications of biopharmaceuticals. For example, in December 2024, the U.S. Food and Drug Administration approved the IL-31 inhibiting biologic Nemluvio (nemolizumab-ilto), developed by Galderma, for patients aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition. 【Contents】 ■ Market Overview ■ Market Analysis (Product Type, Application, Manufacturing Type, Source, End User) ■ Regional Market Analysis ■ Company Profiles

  • Other bio-related products and services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Erythropoietin Preparations

[Research Material] The Global Market for Erythropoietin Preparations

World Market for Erythropoietin Preparations: Epoetin Alpha, Darbepoetin Alpha, Epoetin Beta, Others, Anemia, Kidney Disorders, Others

This research report (Global Erythropoietin Drugs Market) investigates and analyzes the current status and outlook for the global market of erythropoietin preparations over the next five years. It includes information on the overview of the global erythropoietin preparations market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Epoetin Alpha, Darbepoetin Alpha, Epoetin Beta, and others, while the segments by application focus on anemia, kidney disorders, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of erythropoietin preparations. It also includes the market share of major companies in the erythropoietin preparations market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Market for Injectable Muscle Amino Acids, Peptides, and Nucleosides

World Market for Injectable Muscle Amino Acids, Peptides, and Nucleosides

World Market for Injectable Muscle Amino Acids, Peptides, and Nucleosides: 3.5mg, 7mg, 8.75mg, 17.5mg, Hospitals, Dr...

This research report (Global Muscular Amino Acids and Peptides and Nucleosides) investigates and analyzes the current status and outlook for the global market of injectable muscular amino acids, peptides, and nucleosides over the next five years. It includes information on the overview of the global injectable muscular amino acids, peptides, and nucleosides market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for injectable muscular amino acids, peptides, and nucleosides focus on 3.5mg, 7mg, 8.75mg, and 17.5mg, while the segments by application target hospitals, drugstores, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of injectable muscular amino acids, peptides, and nucleosides. It also provides information on the market share of major companies in injectable muscular amino acids, peptides, and nucleosides, product and business overviews, and sales performance, among others.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for CAR-T Therapy in Hematologic Malignancies

[Research Material] The Global Market for CAR-T Therapy in Hematologic Malignancies

Global Market for CAR-T Therapy in Hematologic Malignancies: Allogeneic, Autologous, Hospitals, Cancer Research Centers, Others

This research report (Global CAR-T Therapy in Haematological Malignancy Market) investigates and analyzes the current status and outlook for the global market of CAR-T therapy in hematological malignancies over the next five years. It includes information on the overview of the CAR-T therapy market in global hematological malignancies, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the CAR-T therapy market by type focus on allogeneic and autologous therapies, while the segments by application target hospitals, cancer research centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of CAR-T therapy in hematological malignancies. It also includes the market share of major companies in the CAR-T therapy market for hematological malignancies, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Oral Polymer Formulations

[Research Material] Global Market for Oral Polymer Formulations

Global Market for Oral Polymer Formulations: Capsules, Tablets, Liquids, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

This research report (Global Oral Macromolecule Formulation Market) investigates and analyzes the current status and outlook for the global market of oral macromolecule formulations over the next five years. It includes information on the overview of the global oral macromolecule formulation market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral macromolecule formulation market focus on capsules, tablets, and liquids, while the segments by application target hospital pharmacies, retail pharmacies, online pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of oral macromolecule formulations. It also includes the market share of major companies in oral macromolecule formulations, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Isorhinal Sulfate 2-Sulfatase

[Research Material] Global Market for Isorhinal Sulfate 2-Sulfatase

World Market for Iduronic Acid 2-Sulfatase: Alpha-L-Iduronate Sulfate Sulfatase, Idursulfase, IDS, EC 3.1 ...

This research report (Global Iduronate 2 Sulfatase Market) investigates and analyzes the current status and outlook for the global market of iduronate 2 sulfatase over the next five years. It includes information on the overview of the global iduronate 2 sulfatase market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include alpha-L-iduronate sulfatase, iduronate sulfatase, IDS, and EC 3.1.6.13, while the segments by application focus on hospitals, outpatient surgical centers, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of iduronate 2 sulfatase. It also includes the market share of major companies in iduronate 2 sulfatase, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Glutamate Carboxypeptidase 2

[Research Material] Global Market for Glutamate Carboxypeptidase 2

World Market for Glutamate Carboxypeptidase 2: INO-5150, E-2072, Others, Prostate Cancer, Neuropathic Pain, Cognitive Disorders ...

This research report (Global Glutamate Carboxypeptidase 2 Market) investigates and analyzes the current state and outlook for the global market of glutamate carboxypeptidase 2 over the next five years. It includes information on the overview of the global glutamate carboxypeptidase 2 market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include INO-5150, E-2072, and others, while the segments by application cover prostate cancer, neuropathic pain, cognitive disorders, glioblastoma multiforme, and others. The regional segments calculate the market size of glutamate carboxypeptidase 2 by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in glutamate carboxypeptidase 2, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Oral Solid Dosage Forms

[Research Material] Global Market for Oral Solid Dosage Forms

World Market for Oral Solid Dosage Forms: Immediate Release, Extended Release, Others, Hospital Pharmacies, Retail Pharmacies, Drugstores, Others

This research report (Global Oral Solid Dosage Pharmaceutical Formulation) investigates and analyzes the current state of the global oral solid dosage formulation market and its outlook for the next five years. It includes information on the overview of the global oral solid dosage formulation market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral solid dosage formulation market include immediate release, extended release, and others, while the segments by application cover hospital pharmacies, retail pharmacies, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of oral solid dosage formulations. It also includes the market share of major companies in oral solid dosage formulations, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hospital Formulations

[Research Material] Global Market for Hospital Formulations

Global Market for Hospital Formulations: Antihypertensives, Dyslipidemia Drugs, Alkylating Agents, Antimetabolites, Hormones, Immunomodulators, Other Drugs, Anxiolytics, Antimigraine ...

This research report (Global Hospital Pharmaceuticals Market) investigates and analyzes the current state of the global hospital pharmaceuticals market and its outlook for the next five years. It includes information on the overview of the global hospital pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antihypertensives, dyslipidemia drugs, alkylating agents, antimetabolites, hormones, immunomodulators, other drugs, anxiolytics, antimigraine drugs, and antidepressants. The segments by application focus on cardiovascular diseases, tumors, kidney diseases and urology, neurology, pain, and infectious diseases. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of hospital pharmaceuticals. It also includes the market share of major companies in the hospital pharmaceuticals sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to formulation

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.